nach oben

Erschienen in:

01.07.2021 | Letter to the Editor

Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments

verfasst von: Matthew T. Roe, Bray Patrick-Lake, Andrew C. von Eschenbach

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …

Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open. 2021;4:e210830. https://doi.org/10.1001/jamanetworkopen.2021.0830.CrossRefPubMedPubMedCentral

Moreno-Pérez O, Merino E, Leon-Ramirez J-M, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infection. 2021;82:378–83. https://doi.org/10.1016/j.jinf.2021.01.004.CrossRef

Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021. https://doi.org/10.1016/j.arcmed.2021.03.010.CrossRefPubMedPubMedCentral

Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–15. https://doi.org/10.1038/s41591-021-01283-z.CrossRefPubMed

Rando HM, Bennett TD, Byrd JB, et al. Challenges in defining Long COVID: striking differences across literature, Electronic Health Records, and patient-reported information. Infectious Diseases (except HIV/AIDS). 2021. https://doi.org/10.1101/2021.03.20.21253896.CrossRef

Survivor Corps. Survivor Corps. 2020. https://www.survivorcorps.com. Accessed 2 Mar 2021.

CARE Project—IQVIA COVID-19 Active Research Experience. COVID-19 Active Research Experience. 2020. https://www.helpstopcovid19.com. Accessed 2 Mar 2021.

FDA joins Reagan-Udall, Friends of Cancer Research to form COVID-19 Diagnostics Evidence Accelerator—The Cancer Letter | Reagan-Udall Foundation. 2020. https://reaganudall.org/news-and-events/coverage/fda-joins-reagan-udall-friends-cancer-research-form-covid-19-diagnostics. Accessed 2 Mar 2021.

Sharma A, Harrington RA, McClellan MB, et al. Using digital health technology to better generate evidence and deliver evidence-based care. J Am Coll Cardiol. 2018;71:2680–90. https://doi.org/10.1016/j.jacc.2018.03.523.CrossRefPubMed

10.

Bourke A, Dixon WG, Roddam A, et al. Incorporating patient generated health data into pharmacoepidemiological research. Pharmacoepidemiol Drug Saf. 2020;29:1540–9. https://doi.org/10.1002/pds.5169.CrossRefPubMed

11.

Woody SK, Burdick D, Lapp H, et al. Application programming interfaces for knowledge transfer and generation in the life sciences and healthcare. NPJ Digit Med. 2020;3:24. https://doi.org/10.1038/s41746-020-0235-5.CrossRefPubMedPubMedCentral

12.

Aucott JN, Rebman AW. Long-haul COVID: heed the lessons from other infection-triggered illnesses. Lancet. 2021. https://doi.org/10.1016/S0140-6736(21)00446-3.CrossRefPubMedPubMedCentral

Titel: Post-COVID-19 Syndrome: Leveraging the Patient Perspective and Technological Innovations to Enable the Delineation of Effective Treatments
verfasst von: Matthew T. Roe
Bray Patrick-Lake
Andrew C. von Eschenbach
Publikationsdatum: 01.07.2021
Verlag: Springer International Publishing
Erschienen in: Drugs / Ausgabe 10/2021
Print ISSN: 0012-6667
Elektronische ISSN: 1179-1950
DOI: https://doi.org/10.1007/s40265-021-01548-4